Sunday, March 18, 2018

COPENHAGEN (Reuters) - Lundbeck agreed to buy Prexton Therapeutics, a specialist in treatments for brain disorders, in a deal potentially worth $1.1 billion, the Danish drugmaker said on Friday.


from Reuters: Health News http://ift.tt/2FNpN8m

Related Posts:

  • LATEST HEALTH NEWSMyovant Sciences Ltd said on Tuesday its combination therapy met the main goal of a late-stage study testing the treatment in women with uterine fibroids. from Reuters: Health News https://reut.rs/2PZY9Ll … Read More
  • LATEST HEALTH NEWSVietnam said it will mobilize its military and police forces to help combat the outbreak of African swine fever that has already resulted in the culling of about 4% of the country's pig herd. from Reuters: Health News ht… Read More
  • LATEST HEALTH NEWSMedical cannabis could become an investment bubble in Israel, the country's market regulator warned, as cash floods into a rapidly-expanding industry where few companies yet make money. from Reuters: Health News https://… Read More
  • LATEST HEALTH NEWSThe World Health Organization published its first guidelines on the prevention and management of dementia on Tuesday, putting physical activity at the top of its list of recommendations for preventing cognitive decline. … Read More
  • LATEST HEALTH NEWS(Reuters Health) - Severely obese women who opt for weight-loss surgery may be cutting their risk of breast cancer along with their extra pounds, a large U.S. study suggests. from Reuters: Health News https://reut.rs/30j… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner